Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sigma-Aldrich Corporation    SIAL   US8265521018

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

SIGMA ALDRCH : Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences

05/02/2011 | 08:05am US/Eastern

ST. LOUIS, May 2, 2011 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) will be presenting at the following investor conferences in May:

    --  Deutsche Bank 26th Annual Health Care Conference on Wednesday, May 4,
        2011, at the Intercontinental Boston, Boston, MA, presenting at 10:00 AM
        (ET).

    --  Baird's 2011 Growth Stock Conference on Tuesday, May 10, 2011, at the
        Four Seasons Hotel, Chicago, IL presenting at 11:15 AM (CT).

Interested parties may listen via live audio broadcast over the Internet available at http://investor.sigmaaldrich.com/. Users can click the "Webcast" icon to access this file.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 40 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

SOURCE Sigma-Aldrich Corporation

Latest news on SIGMA-ALDRICH CORPORATION
1d agoSIGMA-ALDRICH CORPORATION : quaterly earnings release
1d ago SIGMA ALDRICH : BioReliance Introduces Advanced In Vitro ADME and Toxicology Ser..
5d ago SIGMA ALDRICH : BioReliance® Introduces Advanced In Vitro ADME and Toxicology Se..
10/14 SIGMA ALDRICH : Cerilliant Introduces Stable-Labeled Certified Reference Materia..
10/09 SIGMA ALDRICH : Expands the Ascentis Express U/HPLC Column Line with addition of..
10/08 SIGMA ALDRICH : reg; Agrees To Acquire Cell Marque To Strengthen Immunohistochem..
10/08 SIGMA ALDRICH : NASDAQ:SIAL) Investor Alert: Lawsuit Filed to Halt the Takeover ..
10/07 SIGMA ALDRICH : Expands the Ascentis® Express U/HPLC Column Line with addition o..
10/07 SIGMA ALDRICH : Agrees To Acquire Cell Marque to Strengthen Immunohistochemistry..
10/03 SIGMA ALDRICH : reg; Agrees To Acquire Cell Marque To Strengthen Immunohistochem..
Dynamic quotes  
ON
| OFF